• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Pediatric Studies Characteristics - Detail

  • Print
  • Share
  • E-mail
-
 
Approval Date:  10/29/2010
 
Trade Name:  Afinitor
 
Generic or Proper Name (*):  everolimus
 
Indications Studied:  Treatment of patients with subependymal giant cell astrocytoma (SEGA) associated with tuberous sclerosis
 
Therapeutic Category:  Antineoplastic
 
Ages Studied:  3 years and older
 
Study #:  1
 
Study Type:  Efficacy/Safety
 
Study Design:  Open Label
 
No Patients:  22
 
No Centers:  1
 
No Countries:  1
 
BPCA(B), PREA(P):  B
 
Asian:  0
 
-
-